STSS_OUT_1 [2025-04-01 04:59:35 -0400] 2240 Bytes | 583 tokens | Cum: 583 tkns (7.29% of 8k)
==========================================================================

We're scouting for winners today. Its 4:59:35 AM on Tue Apr 01, 2025 -0400 and I'm looking at Sharps Technology (STSS) up to 0.0368 from 0.0299

Help me investigate to see if its got potential or just another dud. So, I pulled together a bunch of data for you to look over real fast.

Here's the first list of news for Sharps Technology:

C1 - Mar-20-25 07:00AM - Sharps Technology, Inc. Reminds Shareholders to Vote Before Important Shareholder Meeting on March 28, 2025
C2 - Mar-06-25 07:00AM - Sharps Technology's CEO Issues Corporate Update Highlighting Agreements for SecureGard and SoloGard and Revenue Developments from Manufacturing Operations in Hungary
C3 - Jan-29-25 10:45AM - Sharps Technology, Inc. Announces Closing of Upsized $20.0 Million Underwritten Public Offering
C4 - Jan-28-25 09:00AM - Sharps Technology, Inc. Announces Pricing of Upsized $20.0 Million Underwritten Public Offering
C5 - Dec-05-24 10:00AM - Sharps Technology's CEO Issues Shareholder Letter Highlighting Hungary Manufacturing Facility Expansion Plans to Increase SecureGard and SoloGard Product Supply and Revenue
C6 - Dec-05-24 10:00AM 08:30AM - Sharps Technology Signs Sales Agreements to Support Major European Healthcare Network and Sells Out Its Inventory for SecureGard
C7 - Nov-18-24 08:00AM - Sharps Regains Nasdaq Listing Compliance
C8 - Oct-14-24 08:00AM - Sharps Technology, Inc. Announces Stockholders' Approval of Reverse Stock Split Ratio and Effective Date

ONLY 3 RULES for AI:
==============
1) I am a document retrieval system. You are the analyst-investigator.
2) You can request items from my lists to get more info on Sharps Technology (STSS)
3) AFTER requesting and reading News and SEC filings you'll write a summary, set a score, high price target and headline.
Now, your response should be only 2 or 3 chars. You can say ex., C1, C2, etc., or NEX
The NEX command delivers the NEXt list of News/SEC/Metrics
There are several more lists that use our unified document retrieval system in subsequent prompts.
Your predictons will be compared to reality to rate your accuracy. Try to predict accurately. GOOD LUCK!
Please request a document, read, summarize and score. Say something like "C1".

STSS_OUT_3 [2025-04-01 04:59:39 -0400] 1101 Bytes | 293 tokens | Cum: 878 tkns (10.97% of 8k)
==========================================================================

Showing C2 (chunk 1 of 10): C2:
**Sharps Technology's CEO Issues Corporate Update Highlighting Agreements for SecureGard and SoloGard and Revenue Developments from Manufacturing Operations in Hungary**
Date: Mar-06-25 07:00AM
Source: (GlobeNewswire)
URL: https://www.globenewswire.com/news-release/2025/03/06/3038057/0/en/Sharps-Technology-s-CEO-Issues-Corporate-Update-Highlighting-Agreements-for-SecureGard-and-SoloGard-and-Revenue-Developments-from-Manufacturing-Operations-in-Hungary.html

March 06, 2025 07:00 ET| Source:Sharps Technology IncSharps Technology Inc

As we reflect on the progress since our December update, I am excited to share the latest developments that will shape our Company’s trajectory in 2025 and beyond. With the successful closing of a $20 million financing in January, we strengthened our balance sheet by securing working capital for operating and capital expenditures and paid down our debt to

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

STSS_OUT_5 [2025-04-01 04:59:40 -0400] 1032 Bytes | 302 tokens | Cum: 1254 tkns (15.68% of 8k)
==========================================================================

We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.

A1 - 2025-03-31T12:05:38Z - 12 Health Care Stocks Moving In Monday's Pre-Market Session - Aprea Therapeutics (NASDAQ:APRE), Apol...
A2 - 2025-03-28T20:36:21Z - U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.69% By Investing.com...
A3 - 2025-03-28T20:37:30Z - United States shares lower at close of trade; Dow Jones Industrial Average down 1.69% By Investing.c...
A4 - 2025-03-28T17:05:40Z - 12 Health Care Stocks Moving In Friday's Intraday Session - DBV Technologies (NASDAQ:DBVT), Impact B...
A5 - 2025-03-28T09:58:00Z - Why Braze Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket - Alta Equipm...

Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.

STSS_OUT_7 [2025-04-01 04:59:46 -0400] 1098 Bytes | 336 tokens | Cum: 1592 tkns (19.90% of 8k)
==========================================================================

Showing A1 (chunk 1 of 3): A1:
**12 Health Care Stocks Moving In Monday's Pre-Market Session - Aprea Therapeutics (NASDAQ:APRE), Apollomics (NASDAQ:APLM)**Date: 2025-03-31Source: {'uri': 'benzinga.com', 'dataType': 'news', 'title': 'Benzinga'}URL: https://www.benzinga.com/insights/movers/25/03/44559530/12-health-care-stocks-moving-in-mondays-pre-market-sessionGainers Citius Oncology CTOR stock moved upwards by 66.9% to $1.11 during Monday's pre-market session. The market value of their outstanding shares is at $79.4 million. Corcept Therapeutics CORT shares rose 44.99% to $79.21. The market value of their outstanding shares is at $8.3 billion. Spruce Biosciences SPRB shares moved upwards by 18.6% to $0.35. The market value of their outstanding shares is at $14.4 million. Apollomics APLM shares rose 17.73% to $8.96. The market value of their outstanding shares is at $9.8 million. Know Labs KNW shares moved upwards

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

STSS_OUT_9 [2025-04-01 04:59:47 -0400] 1144 Bytes | 332 tokens | Cum: 2081 tkns (26.01% of 8k)
==========================================================================

This is our final list of news.
News AI can literally read just by asking.
Don't miss the breaking news!

B1 - 2025-03-06T12:00:00Z - Sharps Technology’s CEO Issues Corporate Update Highlighting Agreements for SecureGard and SoloGard and Revenue Developments from Manufacturing Operations in Hungary
B2 - 2024-12-05T15:00:00Z - Sharps Technology’s CEO Issues Shareholder Letter Highlighting Hungary Manufacturing Facility Expansion Plans to Increase SecureGard and SoloGard Product Supply and Revenue
B3 - 2024-09-23T10:00:00Z - Sharps Technology, Inc. Announces $3.5 Million Bridge Financing
B4 - 2024-07-05T19:35:54Z - Gold Gains Over 1%; NIO Shares Slide - Koss (NASDAQ:KOSS) - Benzinga
B5 - 2024-07-05T09:42:31Z - Why Sharps Technology Shares Are Trading Higher By Around 32%; Here Are 20 Stocks Moving Premarket - Sharps ... - Benzinga
B6 - 2024-07-03T17:06:17Z - Sharps Technology Receives Purchase Orders for 1 Million SecureGard Syringes for 2024 Delivery - GlobeNewswire

Request an article by its reference number. (Ex., "B1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

STSS_OUT_11 [2025-04-01 04:59:52 -0400] 943 Bytes | 236 tokens | Cum: 2319 tkns (28.99% of 8k)
==========================================================================

Showing B1 (chunk 1 of 1): B1:
**Sharps Technology’s CEO Issues Corporate Update Highlighting Agreements for SecureGard and SoloGard and Revenue Developments from Manufacturing Operations in Hungary**Date: Unknown DateSource: Unknown SourceURL: https://www.globenewswire.com/news-release/2025/03/06/3038057/0/en/Sharps-Technology-s-CEO-Issues-Corporate-Update-Highlighting-Agreements-for-SecureGard-and-SoloGard-and-Revenue-Developments-from-Manufacturing-Operations-in-Hungary.htmlSharps Technology secures $20 million in financing, advancing manufacturing capabilities in Hungary to accelerate shipments under existing agreements for SecureGard and SoloGard products. The company is well-positioned to capitalize on growing demand for innovative injection solutions.

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

STSS_OUT_13 [2025-04-01 04:59:53 -0400] 1105 Bytes | 291 tokens | Cum: 2671 tkns (33.39% of 8k)
==========================================================================

This is our list of SEC filings.
If empty, the search returned no recent filings.

S1 - 2025-03-27 10-K Item 7. Mgts Discussion and Analysis of Fin Cond and Results of Oper

The following discussion and analysis summarizes the significant factors affecting the CONS operating results, financial condition, liquidity and cash flows of our Company as o...

S2 - 2025-03-20 8-K Item 7.01 Regulation FD Disclosure

On March 20, 2025, Sharps Technology, Inc. (the Company) issued a press release. A copy of the press release is furnished hereto as Exhibit 99.1 and incorporated herein by reference.

Exhibits 9.01 Fin Stmnts and Exhibits

Exhibit ...

S3 - 2025-01-30 8-K Item 1.01 Entry into a Material Definitive Agrmt.

On January 28, 2025, pursuant to the registration statement on Form S-1, as amended (File No. 333-284237) (the Registration Statement), Sharps Technology, Inc., a Nevada corporation (the Company) consummated a public offerin...

Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

STSS_OUT_15 [2025-04-01 04:59:56 -0400] 1098 Bytes | 242 tokens | Cum: 2915 tkns (36.44% of 8k)
==========================================================================

Showing S1 (chunk 1 of 6): S1:
Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis summarizes the significant factors affecting the consolidated operating results, financial condition, liquidity and cash flows of our Company as of and for the periods presented below. The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our audited financial statements and notes included in this Annual Report on Form 10-K as of and for the years ended December 31, 2024 and 2023. Unless the context requires otherwise, references in this Annual Report on Form 10-K to we, us, and our refer to Sharps Technology, Inc.

##TABLE_START 20 ##TABLE_END

Forward-Looking Statements

The information in this discussion contains forward-looking statements and information within the meaning of

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

STSS_OUT_17 [2025-04-01 05:00:07 -0400] 4218 Bytes | 1193 tokens | Cum: 4193 tkns (52.41% of 8k)
==========================================================================

This is our set of metrics.
Please analyze the numbers.

+--------------------+-----------------------+------------------------+--------------------------+
| Volume: 73,948,909 | Perf Month: -89.50% | Option/Short: No / Yes | Sales Y/Y TTM: - |
+--------------------+-----------------------+------------------------+--------------------------+
| Avg Volume: 19.34M | Perf Quarter: -98.51% | Short Float: 25.75% | ROE: -187.23% |
+--------------------+-----------------------+------------------------+--------------------------+
| Rel Volume: 3.82 | Index: - | Short Ratio: 0.14 | ROI: -465.71% |
+--------------------+-----------------------+------------------------+--------------------------+
| RSI (14): 26.16 | Market Cap: 0.49M | Short Interest: 2.70M | Sales Surprise: -100.00% |
+--------------------+-----------------------+------------------------+--------------------------+
| ATR (14): 0.08 | Shs Outstand: 11.08M | Beta: 2.07 | EPS Surprise: -175.00% |
+--------------------+-----------------------+------------------------+--------------------------+
| SMA20: -88.29% | Shs Float: 10.48M | Sales Q/Q: - | P/E: - |
+--------------------+-----------------------+------------------------+--------------------------+
| SMA50: -93.80% | Inst Own: 4.84% | Sales past 5Y: 0.00% | Earnings: - |
+--------------------+-----------------------+------------------------+--------------------------+
| SMA200: -99.08% | Insider Own: 5.36% | Employees: 55 | |
+--------------------+-----------------------+------------------------+--------------------------+
| Perf Week: -82.47% | Insider Trans: 0.85% | Debt/Eq: 1.88 | |
+--------------------+-----------------------+------------------------+--------------------------+

The next section covers any insider trading.
If this section may be blank due to no recent filings.

[Company Financial Summary]
[Company Details]
Name: N/A
Market Cap: N/A
Shares Outstanding: N/A
Sector: N/A

[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): {'value': 0, 'unit': 'USD', 'label': 'Revenues', 'order': 100}
Net Income: {'value': -9296202.0, 'unit': 'USD', 'label': 'Net Income/Loss', 'order': 3200}
Earnings Per Share (EPS): N/A

[Price Metrics - Last 30 Days]
Latest Close: 0.0299
Average Volume: 51627966.19
30-Day High: 0.44
30-Day Low: 0.0299

[Detailed Financials: TTM 2024]
- Total Assets: $7,313,748.0
- Total Liabilities: $5,317,619.0
- Total Equity: $1,996,129.0
- Current Assets: $3,173,940.0
- Current Liabilities: $5,185,619.0

[Income Statement: TTM 2024]
- Revenue: $0.00
- Net Income: N/A
- Gross Profit: N/A
- Operating Income: N/A
- Earnings Per Share (EPS): -7.4

[Cash Flow Statement: TTM 2024]
- Net Cash Flow: $-2,185,274.0

[Detailed Financials: FY 2024]
- Total Assets: $7,313,748.0
- Total Liabilities: $5,317,619.0
- Total Equity: $1,996,129.0
- Current Assets: $3,173,940.0
- Current Liabilities: $5,185,619.0

[Income Statement: FY 2024]
- Revenue: $0.00
- Net Income: N/A
- Gross Profit: N/A
- Operating Income: N/A
- Earnings Per Share (EPS): -7.4

[Cash Flow Statement: FY 2024]
- Net Cash Flow: $-2,185,274.0
==== END OF FINANCIAL REPORT ====

You are now requested to make a summary analysis.
Save explaining why you didn't have enough information for the final survey.

Now, complete this report with the following:

1) Brief Summary: explain your findings in succinct wording.
2) MARKET_SCORE: If you calculate a 92% likelihood of an upward moves, say: MARKET_SCORE[92]
3) PRICE_TARGET: If you think the high today will be 50% higher, add to the price.
Eg., If the current price is $5.00, add 50%. Thus, PRICE_TARGET[$7.50] -- It should be at or above the current price.
4) Provide a thought-provoking take, 6-10 words, to use for the headline of this news story.
Like this: AI_RPT_HEADLINE: [6-12 words headline for news story, distilled from summary]

1) Brief Summary, 2) MARKET_SCORE, 3) PRICE_TARGET, and 4) AI_RPT_HEADLINE

STSS_OUT_19 [2025-04-01 05:00:10 -0400] 676 Bytes | 167 tokens | Cum: 4618 tkns (57.73% of 8k)
==========================================================================

Finally, if more data could have improved your confidence which would you have chosen? **Choose one option:**
-> X0 <- Nothing more would have helped my analysis
-> X1 <- More stock-specific news
-> X2 <- More SEC filings (10-K, 10-Q, 8-K) Financials, risk disclosures, and business changes
-> X3 <- More SEC Insider Trading (Form 3, 4, 5) Direct buys/sells from executives and institutions
-> X4 <- Broader sector & market news
-> X5 <- Your past analysis on similar companies (specify metrics)
-> X6 <- More financial metrics
-> X7 <- Your past analysis on this exact company
-> X8 <- Something altogether different (explain...)

STSS_IN_21 [2025-04-01 05:00:10 -0400] 126 Bytes | 29 tokens | Cum: 4709 tkns (58.86% of 8k)
==========================================================================

====================================
[2025-04-01 05:00:10] # Analysis Completed
Elapsed Time: 35.98 seconds